22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/18/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/18/22 | 8-K | Current report filing |
|
   |
43 |
| 05/13/22 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
3 | |
| 05/05/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
38 |
| 05/05/22 | 8-K | Current report filing |
|
|
29 |
| 04/25/22 | DEF 14A | Definitive proxy statements |
|
33 | |
| 03/23/22 | 4/A | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/23/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/23/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/23/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
